Laboratory of Molecular Immunology, The Rockefeller University, New York, USA.
Adv Immunol. 2011;110:1-26. doi: 10.1016/B978-0-12-387663-8.00005-3.
Antibody maturation requires class switch recombination (CSR) and somatic hypermutation (SHM), both of which are initiated by activation-induced cytidine deaminase (AID). AID deaminates cytosine residues resulting in mismatches that are differentially processed to produce double-strand breaks in Ig switch (S) regions that lead to CSR, or to point mutations in variable (V) exons resulting in SHM. Although AID was first thought to be Ig-specific, recent work indicates that it also targets a diverse group of non-Ig loci, including genes such as Bcl6 and c-myc, whose modification by AID results in lymphoma-associated mutations and translocations. Here, we review the recent literature on AID targeting and the role for transcriptional stalling in recruitment of this enzyme to Ig and non-Ig loci. We propose a model for AID recruitment based on transcriptional stalling, which reconciles several of the key features of SHM, CSR, and lymphoma-associated translocation.
抗体成熟需要类别转换重组 (CSR) 和体细胞高频突变 (SHM),这两者均由激活诱导胞嘧啶脱氨酶 (AID) 引发。AID 使胞嘧啶残基脱氨基,导致错配,这些错配通过不同的方式进行处理,在 Ig 开关 (S) 区产生双链断裂,导致 CSR,或者在可变 (V) 外显子中产生点突变,导致 SHM。尽管最初认为 AID 是 Ig 特异性的,但最近的研究表明,它还靶向一组不同的非 Ig 基因座,包括 Bcl6 和 c-myc 等基因,AID 对这些基因的修饰导致淋巴瘤相关的突变和易位。在这里,我们综述了关于 AID 靶向和转录停滞在招募这种酶到 Ig 和非 Ig 基因座中的作用的最新文献。我们提出了一个基于转录停滞的 AID 招募模型,该模型解释了 SHM、CSR 和淋巴瘤相关易位的几个关键特征。